Development of the Double Cyclic Peptide Ligand for Antibody Purification and Protein Detection

Bioconjugate Chemistry

Volumn 27, Issue 7, 2016, Pages 1569-1573

  Gong, Yiyi ^a   Zhang, Lin ^a,b   Li, Jin ^a   Feng, Shan ^b   Deng, Haiteng ^a  

^a China   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANTIBODIES; BINDING ENERGY; CHEMICAL DETECTION; COVALENT BONDS; LIGANDS; PURIFICATION; REUSABILITY; SULFUR COMPOUNDS;

AFFINITY MATRIX; ANTIBODY PURIFICATION; BIOMEDICAL RESEARCH; BIOPHARMACEUTICAL INDUSTRY; CYCLIC PEPTIDES; DETECTION REAGENTS; IMMUNOGLOBIN G; PEPTIDE LIGAND; PROTEIN A; PROTEIN DETECTION;

PEPTIDES;

AGAROSE; CYCLOPEPTIDE; CYSTEINE; FC III 4C PEPTIDE; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; LIGAND;

ARTICLE; BOVINE; DISULFIDE BOND; GOAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; HUMAN; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PIG; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN PURIFICATION; RABBIT; RAT; SOLID PHASE SYNTHESIS; SURFACE PLASMON RESONANCE; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; CHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR MODEL; PROTEIN CONFORMATION; SYNTHESIS;

AMINO ACID SEQUENCE; HUMANS; IMMUNOGLOBULIN G; LIGANDS; MODELS, MOLECULAR; PEPTIDES, CYCLIC; PROTEIN CONFORMATION;

EID: 84979519890     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.6b00170     Document Type: Article

References (12)

1. Sidhu, S. S., Fairbrother, W. J., and Deshayes, K. (2003) Exploring protein-protein interactions with phage display ChemBioChem 4, 14-25 10.1002/cbic.200390008
2. Dwyer, M. A., Lu, W., Dwyer, J. J., and Kossiakoff, A. A. (2000) Biosyntheitc phage display: a novel protein engineering tool combining chemical and genetic diversity Chem. Biol. 7, 263-274 10.1016/S1074-5521(00)00102-2
3. Hruby, V. J. and Cai, M. (2013) Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles Annu. Rev. Pharmacol. Toxicol. 53, 557-580 10.1146/annurev-pharmtox-010510-100456
4. Nilsson, J., Stahl, S., Lundeberg, J., Uhlen, M., and Nygren, P. (1997) Affinity Fusion Strategies for Detection, Purification, and Immobilization of Recombinant Proteins Protein Expression Purif. 11, 1-16 10.1006/prep.1997.0767
5. Terpe, K. (2003) Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems Appl. Microbiol. Biotechnol. 60, 523-533 10.1007/s00253-002-1158-6
6. Malhotra, A. (2009) Tagging for protein expression Methods Enzymol. 463, 239-258 10.1016/S0076-6879(09)63016-0
7. Uhlen, M., Forsberg, M. T., Hartmanis, M., Nilsson, B., and Moks, M. (1992) Fusion proteins in biotechnology Curr. Opin. Biotechnol. 3, 363-369 10.1016/0958-1669(92)90164-E
8. DeLano, W. L., Ultsch, M. H., de Vos, A. M., and Wells, J. A. (2000) Convergent solution to binding at a protein-protein interface Science 287, 1279-1283 10.1126/science.287.5456.1279
9. Dias, R. L., Fasan, R., Moehle, K., Renard, A., Obrecht, D., and Robinson, J. A. (2006) Protein ligand design: from phage display to synthetic protein epitope mimetics in human antibody Fc-binding peptidomimetics J. Am. Chem. Soc. 128, 2726-2732 10.1021/ja057513w
10. Williams, Rc, Jr., Shah, C., and Sackett, D. (1999) Separation of tubulin isoforms by isoelectric focusing in immobilized pH gradient gels Anal. Biochem. 275, 265-267 10.1006/abio.1999.4326
11. Cazzalini, O., Sommatis, S., Tillhon, M., Dutto, I., Bachi, A., Rapp, A., Nardo, T., Scovassi, A. I., Necchi, D., Cardoso, M. C., Stivala, L. A., and Prosperi, E. (2014) CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis Nucleic Acids Res. 42, 8433-8448 10.1093/nar/gku533
12. Leonardi, E., Girlando, S., Serio, G., Mauri, F. A., Perrone, G., Scampini, S., Dalla Palma, P., and Barbareschi, M. (1992) PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables J. Clin. Pathol. 45, 416-419 10.1136/jcp.45.5.416